- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Advances in COPD II
Special Issue Information
Dear Colleagues,
Chronic obstructive pulmonary disease (COPD) is the third world leading cause of death. COPD is a complex disease presenting airflow obstruction alongside systemic conditions associated with inflammation and alterations in repair mechanisms. Among the risk factors, the inhalation of cigarette smoke and other harmful particles is the most prominent. Synergistic effects such as excess body fat, poor nutrition, respiratory infections during childhood, and poor housing conditions are associated with a higher prevalence of COPD. Comorbid disease potentiates the morbidity of COPD, leading to hospitalizations, mortality, and healthcare costs. The complexity and heterogeneity of this disease hinder the development of novel treatments. New data on possible basic mechanisms at the cellular and molecular level addressing the complexity and heterogeneity of lung and systemic COPD will support advances in health treatment and care.
This Special Issue aims to summarize advances in the COPD area of research, including studies on epidemiology, diagnostics tools, the basic mechanisms in COPD, pharmacotherapy, rehabilitation, and skeletal muscle comorbidity and emerging therapies.
We look forward to your contribution
Dr. Davina C. M. Simoes
Dr. Esther Barreiro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- progress on COPD research
- epidemiological insights
- diagnostics tools
- physiological insights
- clinical management
- non-pharmacological therapeutic strategies
- new insights on pharmacological treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Related Special Issues
- Advances in COPD IIinCells (1 article)
- Advances in COPD IIinCells (1 article)

